Skip to content
Advertisements

What LDC graduation will mean for Bangladesh’s drugs industry

December 18, 2017

Bangladesh’s pharmaceutical industry is unique among least developed countries (LDCs). Driven by active government policies, output has grown a thousand times since 1982, to US$2 billion, or around 1% of gross domestic product, making it the biggest white collar employer in the country. The industry supplies almost the entire domestic market and more than 100 other countries including the United States.

It’s of some concern, then, that if Bangladesh potentially leaves the LDC category in 2024 it’ll no longer have access to a special World Trade Organisation waiver which exempts the industry from the Agreement on Trade-Related Aspects of International Property Rights. The exemption has allowed government to pursue a dedicated industrial policy that’s spurred growth until now.

Continues here.

Advertisements
No comments yet

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: